MoonLake Immunotherapeutics Quarterly Operating Income (Loss) in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MoonLake Immunotherapeutics quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
  • MoonLake Immunotherapeutics Operating Income (Loss) for the quarter ending September 30, 2024 was -$43.1M, a 232% decline year-over-year.
  • MoonLake Immunotherapeutics Operating Income (Loss) for the twelve months ending September 30, 2024 was -$109M, a 94.5% decline year-over-year.
  • MoonLake Immunotherapeutics annual Operating Income (Loss) for 2023 was -$54.1M, a 16.8% increase from 2022.
  • MoonLake Immunotherapeutics annual Operating Income (Loss) for 2022 was -$65.1M, a 1324% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$109M -$43.1M -$30.1M -232% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$78.4M -$30.6M -$17.4M -132% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$61M -$19.8M -$6.89M -53.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$54.1M -$15M +$1.67M +9.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$55.8M -$13M +$1.79M +12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$57.6M -$13.2M +$4.47M +25.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$62.1M -$12.9M +$3.01M +18.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$65.1M -$16.7M -$51.2M -148% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$13.9M -$14.8M -$8.5M -136% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$5.39M -$17.7M +$15M +46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$20.4M -$15.9M -$15.8M -16841% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$4.57M $34.5M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-17
Q3 2021 -$6.27M -$6.26M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$32.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$94.1K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$5K* Aug 13, 2020 Sep 30, 2020 10-Q/A 2021-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.